Novel Approaches Against Emerging Antimicrobial Resistance

NIH RePORTER · NIH · R13 · $11,000 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Support is requested for a Keystone Symposia conference entitled Novel Approaches Against Emerging Antimicrobial Resistance, organized by Drs. Man-Wah Tan and Deborah T. Hung. The conference will be held in Banff, Alberta, Canada from February 13-16, 2022. It has become clear that infectious diseases are among the greatest threats to human health and global stability. Chief among these threats is the rise in antibiotic resistance, which endangers our ability to treat otherwise curable infections. The capacity to discover and develop novel agents to fill the pipeline as existing antibiotics are lost to increasing resistance has to date been limited. The goal of this Keystone Symposia conference is to present cutting-edge approaches to antibiotic discovery, including application of expanded chemical space, systems chemical biology, and artificial intelligence and novel strategies for treating resistant infection, including CRISPR, vaccines, antibodies, phages and conjugates. The promise, challenges, and development paths of these new approaches and strategies will be discussed in the context of lessons learned from prior antibiotic development programs, and new innovations in clinical and regulatory pathways. Additionally, this conference will be held jointly with “The Human Microbiome: Ecology and Evolution.” This pairing will help to facilitate exploration of the impact of antibiotics on the microbiome and the microbiome on antibiotic resistance.

Key facts

NIH application ID
10391767
Project number
1R13AI167430-01
Recipient
KEYSTONE SYMPOSIA
Principal Investigator
Thale Cross Jarvis
Activity code
R13
Funding institute
NIH
Fiscal year
2022
Award amount
$11,000
Award type
1
Project period
2022-02-01 → 2023-01-31